Cyclic pamidronate therapy in children with osteogenesis imperfecta: Results of treatment and follow-up after discontinuation


Andiran N., ALİKAŞİFOĞLU A., Gonc N., Ozon A., KANDEMİR N., Yordarn N.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.21, sa.1, ss.63-72, 2008 (SCI-Expanded) identifier identifier

Özet

Background. Cyclic intravenous pamidronate treatment is widely used for symptomatic therapy of osteogenesis imperfecta (01). However, data after discontinuation are very limited.